Perbedaan Fimperkasa Utama Tbk. dan Charlie Hospital Semarang Tbk.: Fimperkasa Utama Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 27,6 M), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp430 (kapitalisasi pasar 1,11 T, volume 24 jam 25,61 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 40,2× kapitalisasi pasar Fimperkasa Utama Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FIMP | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 27,6 M | 1,11 T |
Volume | — | 25,61 jt |
Lot | — | 256,07 rb |
Perputaran | — | 10,76 M |
Harga Rata-rata | — | 420,16 |
Nilai Transaksi | — | 10,76 M |
Harga Ekuilibrium Indikatif | — | 430 |
Volume Ekuilibrium Indikatif | — | 1,46 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fimperkasa Utama Tbk (the "Company”) established in Indonesia based on Notarial Deed No. 41 of Adam Kasdarmadji, S.H., on February 08, 1993. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Mohamad Mulky Thalib,
Selengkapnya di halaman FIMP →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →